# A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis

> **NCT03634475** · PHASE1,PHASE2 · COMPLETED · sponsor: **Panoptes Pharma GmbH** · enrollment: 12 (actual)

## Conditions studied

- Non-infectious Uveitis

## Interventions

- **DRUG:** PP-001

## Key facts

- **NCT ID:** NCT03634475
- **Lead sponsor:** Panoptes Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-11
- **Final completion:** 2019-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634475, "A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03634475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*